INGN
Price
$10.47
Change
-$0.05 (-0.48%)
Updated
Jan 17 closing price
Capitalization
176.12M
45 days until earnings call
ZBH
Price
$109.56
Change
+$0.62 (+0.57%)
Updated
Jan 17 closing price
Capitalization
27.12B
18 days until earnings call
Ad is loading...

INGN vs ZBH

Header iconINGN vs ZBH Comparison
Open Charts INGN vs ZBHBanner chart's image
Inogen
Price$10.47
Change-$0.05 (-0.48%)
Volume$149.53K
Capitalization176.12M
Zimmer Biomet Holdings
Price$109.56
Change+$0.62 (+0.57%)
Volume$1.1M
Capitalization27.12B
INGN vs ZBH Comparison Chart
Loading...
INGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INGN vs. ZBH commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INGN is a Hold and ZBH is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (INGN: $10.47 vs. ZBH: $109.56)
Brand notoriety: INGN and ZBH are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: INGN: 83% vs. ZBH: 71%
Market capitalization -- INGN: $176.12M vs. ZBH: $27.12B
INGN [@Medical Specialties] is valued at $176.12M. ZBH’s [@Medical Specialties] market capitalization is $27.12B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INGN’s FA Score shows that 0 FA rating(s) are green whileZBH’s FA Score has 1 green FA rating(s).

  • INGN’s FA Score: 0 green, 5 red.
  • ZBH’s FA Score: 1 green, 4 red.
According to our system of comparison, both INGN and ZBH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INGN’s TA Score shows that 5 TA indicator(s) are bullish while ZBH’s TA Score has 4 bullish TA indicator(s).

  • INGN’s TA Score: 5 bullish, 5 bearish.
  • ZBH’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, ZBH is a better buy in the short-term than INGN.

Price Growth

INGN (@Medical Specialties) experienced а +9.63% price change this week, while ZBH (@Medical Specialties) price change was +4.80% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.94%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +1.30%.

Reported Earning Dates

INGN is expected to report earnings on May 13, 2025.

ZBH is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Medical Specialties (+0.94% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZBH($27.1B) has a higher market cap than INGN($176M). INGN has higher P/E ratio than ZBH: INGN (71.43) vs ZBH (26.59). INGN YTD gains are higher at: 14.177 vs. ZBH (3.721). ZBH has higher annual earnings (EBITDA): 2.22B vs. INGN (-58.34M). ZBH has more cash in the bank: 416M vs. INGN (128M). INGN has less debt than ZBH: INGN (21.9M) vs ZBH (5.91B). ZBH has higher revenues than INGN: ZBH (7.39B) vs INGN (316M).
INGNZBHINGN / ZBH
Capitalization176M27.1B1%
EBITDA-58.34M2.22B-3%
Gain YTD14.1773.721381%
P/E Ratio71.4326.59269%
Revenue316M7.39B4%
Total Cash128M416M31%
Total Debt21.9M5.91B0%
FUNDAMENTALS RATINGS
INGN vs ZBH: Fundamental Ratings
INGN
ZBH
OUTLOOK RATING
1..100
1514
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
17
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9574
PRICE GROWTH RATING
1..100
3854
P/E GROWTH RATING
1..100
6579
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZBH's Valuation (17) in the Medical Specialties industry is somewhat better than the same rating for INGN (80). This means that ZBH’s stock grew somewhat faster than INGN’s over the last 12 months.

ZBH's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as INGN (100). This means that ZBH’s stock grew similarly to INGN’s over the last 12 months.

ZBH's SMR Rating (74) in the Medical Specialties industry is in the same range as INGN (95). This means that ZBH’s stock grew similarly to INGN’s over the last 12 months.

INGN's Price Growth Rating (38) in the Medical Specialties industry is in the same range as ZBH (54). This means that INGN’s stock grew similarly to ZBH’s over the last 12 months.

INGN's P/E Growth Rating (65) in the Medical Specialties industry is in the same range as ZBH (79). This means that INGN’s stock grew similarly to ZBH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INGNZBH
RSI
ODDS (%)
Bearish Trend 5 days ago
82%
Bullish Trend 5 days ago
53%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
82%
Bullish Trend 5 days ago
68%
Momentum
ODDS (%)
Bullish Trend 5 days ago
80%
Bearish Trend 5 days ago
54%
MACD
ODDS (%)
Bullish Trend 5 days ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 5 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
75%
Bearish Trend 5 days ago
56%
Advances
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 6 days ago
66%
Declines
ODDS (%)
Bearish Trend 12 days ago
83%
Bearish Trend 11 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 5 days ago
66%
Aroon
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
51%
View a ticker or compare two or three
Ad is loading...
INGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

INGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, INGN has been loosely correlated with VCYT. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if INGN jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INGN
1D Price
Change %
INGN100%
-0.48%
VCYT - INGN
41%
Loosely correlated
-1.27%
SNN - INGN
38%
Loosely correlated
+0.96%
IMTH - INGN
37%
Loosely correlated
N/A
ZBH - INGN
34%
Loosely correlated
+0.57%
SHC - INGN
34%
Loosely correlated
+2.29%
More

ZBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZBH has been loosely correlated with MDT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ZBH jumps, then MDT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZBH
1D Price
Change %
ZBH100%
+0.57%
MDT - ZBH
51%
Loosely correlated
+1.06%
SYK - ZBH
48%
Loosely correlated
+0.43%
BSX - ZBH
47%
Loosely correlated
+0.50%
ISRG - ZBH
44%
Loosely correlated
+1.47%
COO - ZBH
42%
Loosely correlated
+1.34%
More